Medical News

RSS

AHF members urge Congress to honor AIDS funding commitment

Five AIDS treatment clients and medical care providers from Uganda are visiting Washington, DC for a series of over 50 meetings this week on Capitol Hill with Senate and Congressional leaders to lobby Congress to honor the US' landmark commitment to PEPFAR (the President's Emergency Plan for AIDS Relief), the successful US global AIDS program.

2 Jul 2010

Advanced Analytical opens new sales office, lab in Technologiepark at Heidelberg University

Advanced Analytical, headquartered in Ames, IA, has opened a new sales office and laboratory in Heidelberg Germany. The new facility is located in the Technologiepark on the campus of the Heidelberg University. By opening this office, the company will be able to provide better representation over sales for our suite of products sold as well as provide better support and service for our current and future customer base.

2 Jul 2010

Governors to Congress: Restore extra Medicaid funds

Kaiser Health News staff writer Jenny Gold caught up with Kansas Gov. Mark Parkinson, a Democrat, after a Washington press conference to discuss the current enhanced federal share of Medicaid funds set to expire at the end of the year and the devastating impact on state budgets that Congress' failure to provide additional federal Medicaid assistance could have (Gold, 6/30).

2 Jul 2010

Advanced Cancer Therapeutics secures $10M in investments

Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has secured $10 million in investments from high net-worth individuals and institutions. This round of investment, which closed six months ahead of the company's year-end goal, will provide ACT additional capital to continue its development and commercialization of potentially lifesaving therapeutics for cancer patients.

2 Jul 2010

Medical school association suggests clinical conflict-of-interest policies

The Association of American Medical Colleges has asked academic medical institutions to adopt conflict-of-interest policies for clinical care similar to those they apply to medical research, Modern Healthcare reports.

2 Jul 2010

New asthma therapy shows promise for patients who do not respond to steroid treatments

A new nonsteroidal, anti-inflammatory therapy made from a human protein significantly decreases disease signs of asthma in mice, opening the possibility of a new asthma therapy for patients who do not respond to current steroid treatments. Results of this therapy in an animal model were presented at The Endocrine Society's 92nd Annual Meeting in San Diego.

2 Jul 2010

Abortion opponents focusing legislative efforts on the fetus

NPR explores a recent flurry of state legislative efforts to restrict abortions and the new strategy by groups opposed to the procedure. "More than a dozen states passed new laws aimed at limiting abortion this year.

2 Jul 2010

Lupin's Famotidine for Oral Suspension receives FDA approval

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the US Food and Drug Administration (FDA) for its Famotidine for Oral Suspension (40 mg / 5 mL). Commercial shipments of the product have already commenced.

2 Jul 2010

Does too much texting puts teenagers at risk?

A seemingly harmless method of communication - text messaging on mobile phones could damage teenagers physically and psychologically a new study has revealed.

1 Jul 2010

Patel verdict “grossly inadequate”

Many including Queensland MP Rob Messenger, feel that the seven year sentence awarded to Dr. Jayant Patel by the Brisbane's Supreme Court yesterday is “grossly inadequate.” Patel was being tried for three cases of manslaughter and one case of grievous bodily injury during his tenure as Director of Surgery at Bundaberg Base hospital between 2003 and 2005.

1 Jul 2010

Wound Care Innovations signs distribution agreement with KOMED for CellerateRx

Wound Management Technologies, Inc. announced an important milestone in its planned growth strategy. Its wholly owned subsidiary Wound Care Innovations signed a distribution agreement with KOMED, LLC of Georgia for direct response advertising on television and niche online marketing of CellerateRx® in the United States.

1 Jul 2010

SAIC-Frederick, Fluidigm collaborate to decode entire genome of Epstein-Barr virus

SAIC-Frederick, Inc. and Fluidigm Corporation are collaborating to decode the entire genome of the Epstein-Barr virus (EBV) using technology that can speed up research on the genetic basis of cancer and other diseases.

1 Jul 2010

Fidelitone to provide logistics services for OROMed Healthcare

Fidelitone Logistics, an industry leader in third-party logistics and supply chain performance, has been selected to provide logistics services for OROMed Healthcare, a leading manufacturer of fully automatic, adjustable sleep systems.

1 Jul 2010

Diagnostic Hybrids receives Chinese SFDA approval for D3 Ultra DFA Respiratory Virus Screening and ID Kit

Diagnostic Hybrids, a Quidel Company, received approval from the People's Republic of China's State Food and Drug Administration (SFDA) for its D3 Ultra DFA Respiratory Virus Screening and ID Kit. The D3 Ultra DFA Respiratory Virus Screening and ID Kit is a direct fluorescence assay (DFA) that provides rapid, sensitive and specific screening and identification of Influenza A, Influenza B, Parainfluenza 1, 2, & 3, Respiratory Syncytial Virus and Adenovirus.

1 Jul 2010

Almost Family receives civil subpoena for documents and notice of investigation from SEC

Almost Family, Inc., a leading regional provider of home health nursing services, announced today that on June 30, 2010 it received a civil subpoena for documents and notice of investigation from the Securities and Exchange Commission.

1 Jul 2010

Hospira subsidiary completes tender offer for Javelin's outstanding shares of common stock

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..

1 Jul 2010

Advanced Life Sciences prices securities offering

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that it has established the pricing terms of its proposed offering of units.

1 Jul 2010

FIOCRUZ receives Brazil's Anvisa regulatory approval to market Chembio's Dual Path Platform HIV 1/2 rapid test

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, has been notified that Bio-Manguinhos, a division of the Oswaldo Cruz Foundation of Brazil ("FIOCRUZ"), has received regulatory approval from Brazil's National Health Surveillance Agency (Anvisa) to market Chembio's Dual Path Platform (DPP®) HIV 1/2 rapid test for use with oral fluid, blood, serum or plasma samples. The approval triggers $400,000 in license revenues payable to Chembio within 120 days of the date of approval.

1 Jul 2010

Watson commences shipment of generic Exelon

Watson Pharmaceuticals, Inc. announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic version of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules. Exelon® is used to treat dementia in people with Alzheimer's disease.

1 Jul 2010

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress.

1 Jul 2010

Medical News

AHF members urge Congress to honor AIDS funding commitment

Advanced Analytical opens new sales office, lab in Technologiepark at Heidelberg University

Governors to Congress: Restore extra Medicaid funds

Advanced Cancer Therapeutics secures $10M in investments

Medical school association suggests clinical conflict-of-interest policies

New asthma therapy shows promise for patients who do not respond to steroid treatments

Abortion opponents focusing legislative efforts on the fetus

Lupin's Famotidine for Oral Suspension receives FDA approval

Does too much texting puts teenagers at risk?

Patel verdict “grossly inadequate”

Wound Care Innovations signs distribution agreement with KOMED for CellerateRx

SAIC-Frederick, Fluidigm collaborate to decode entire genome of Epstein-Barr virus

Fidelitone to provide logistics services for OROMed Healthcare

Diagnostic Hybrids receives Chinese SFDA approval for D3 Ultra DFA Respiratory Virus Screening and ID Kit

Almost Family receives civil subpoena for documents and notice of investigation from SEC

Hospira subsidiary completes tender offer for Javelin's outstanding shares of common stock

Advanced Life Sciences prices securities offering

FIOCRUZ receives Brazil's Anvisa regulatory approval to market Chembio's Dual Path Platform HIV 1/2 rapid test

Watson commences shipment of generic Exelon

ThromboGenics to present microplasmin Phase III trial data at 28th ASRS and 10th EURETINA Congress

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News